Article Text
Correspondence
Reply: further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy
Statistics from Altmetric.com
Footnotes
Contributors LYL is responsible for the overall content as a guarantor, and contributed to the conception and design of the work, acquisition and interpretation of the data and critical revision of the manuscript for important intellectual content. CYH contributed to the conception and design of the work, analysis and interpretation of data for the work, drafting of the manuscript and revising the manuscript.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; internally peer reviewed.